Literature DB >> 20920653

Effect of serum insulin on the association between hyperuricemia and incident heart failure.

Ravi V Desai1, Mustafa I Ahmed, Gregg C Fonarow, Gerasimos S Filippatos, Michel White, Inmaculada B Aban, Wilbert S Aronow, Ali Ahmed.   

Abstract

Increased serum uric acid (UA) is associated with incident heart failure (HF). However, whether it is a direct effect of UA or an effect of increased xanthine oxidase (XO) is unknown. Because hyperuricemia in hyperinsulinemia is primarily due to impaired renal UA excretion, its association with incident HF would suggest a direct UA effect. In contrast, hyperuricemia in normoinsulinemia is likely due to increased UA production and thus its association with incident HF would suggest an XO effect. To clarify this, we examined the association of hyperuricemia with centrally adjudicated incident HF in Cardiovascular Health Study participants with and without hyperinsulinemia. Of the 5,411 participants ≥ 65 years of age without baseline HF, 1,491 (28%) had hyperuricemia (serum UA ≥ 6 mg/dl for women and ≥ 7 mg/dl for men). Propensity scores for hyperuricemia were estimated using 63 baseline characteristics. Mean serum UA levels were 6.0 and 5.3 mg/dl in those with (n = 2,731) and those without (n = 2,680) hyperinsulinemia (median serum insulin ≥ 13 mU/L), respectively (p < 0.001). Propensity-adjusted hazard ratios (95% confidence intervals) for hyperuricemia-associated incident HF during 8 years of median follow-up were 0.99 (0.83 to 1.18, p = 0.886) and 1.32 (1.04 to 1.67, p = 0.021) for those with and without hyperinsulinemia respectively (p for interaction = 0.014). In conclusion, the absence of an association of hyperuricemia with incident HF in those with hyperinsulinemia (despite a significantly higher mean serum UA) and a significant association in normoinsulinemia suggest that UA has no intrinsic association with incident HF and that it may predict incident HF when it is a marker of increased of XO activity. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20920653      PMCID: PMC2998195          DOI: 10.1016/j.amjcard.2010.06.023

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  21 in total

1.  Increased oxidative stress and cardiomyocyte myofibrillar degeneration in patients with chronic isolated mitral regurgitation and ejection fraction >60%.

Authors:  Mustafa I Ahmed; James D Gladden; Silvio H Litovsky; Steven G Lloyd; Himanshu Gupta; Seidu Inusah; Thomas Denney; Pamela Powell; David C McGiffin; Louis J Dell'Italia
Journal:  J Am Coll Cardiol       Date:  2010-02-16       Impact factor: 24.094

2.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

3.  Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study.

Authors:  J S Gottdiener; A M Arnold; G P Aurigemma; J F Polak; R P Tracy; D W Kitzman; J M Gardin; J E Rutledge; R C Boineau
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

4.  Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology.

Authors:  Joshua M Hare; Richard J Johnson
Journal:  Circulation       Date:  2003-04-22       Impact factor: 29.690

5.  Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey.

Authors:  J Fang; M H Alderman
Journal:  JAMA       Date:  2000-05-10       Impact factor: 56.272

6.  Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study.

Authors:  O James Ekundayo; Louis J Dell'Italia; Paul W Sanders; Donna Arnett; Inmaculada Aban; Thomas E Love; Gerasimos Filippatos; Stefan D Anker; Donald M Lloyd-Jones; George Bakris; Marjan Mujib; Ali Ahmed
Journal:  Int J Cardiol       Date:  2009-02-06       Impact factor: 4.164

7.  The relationship of fasting serum radioimmune insulin levels to incident coronary heart disease in an insulin-treated diabetic cohort.

Authors:  Richard A Kronmal; Joshua I Barzilay; Russell P Tracy; Peter J Savage; Trevor J Orchard; Gregory L Burke
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

8.  Effect of insulin on uric acid excretion in humans.

Authors:  A Quiñones Galvan; A Natali; S Baldi; S Frascerra; G Sanna; D Ciociaro; E Ferrannini
Journal:  Am J Physiol       Date:  1995-01

9.  Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration.

Authors:  F Facchini; Y D Chen; C B Hollenbeck; G M Reaven
Journal:  JAMA       Date:  1991-12-04       Impact factor: 56.272

10.  Physiologic levels of uric acid inhibit xanthine oxidase in human plasma.

Authors:  S Tan; R Radi; F Gaudier; R A Evans; A Rivera; K A Kirk; D A Parks
Journal:  Pediatr Res       Date:  1993-09       Impact factor: 3.756

View more
  16 in total

1.  A propensity-matched study of the association of diabetes mellitus with incident heart failure and mortality among community-dwelling older adults.

Authors:  Brita Roy; Pushkar P Pawar; Ravi V Desai; Gregg C Fonarow; Marjan Mujib; Yan Zhang; Margaret A Feller; Fernando Ovalle; Inmaculada B Aban; Thomas E Love; Ami E Iskandrian; Prakash Deedwania; Ali Ahmed
Journal:  Am J Cardiol       Date:  2011-09-22       Impact factor: 2.778

2.  Uric Acid Is a Strong Risk Marker for Developing Hypertension From Prehypertension: A 5-Year Japanese Cohort Study.

Authors:  Masanari Kuwabara; Ichiro Hisatome; Koichiro Niwa; Shigeko Hara; Carlos A Roncal-Jimenez; Petter Bjornstad; Takahiko Nakagawa; Ana Andres-Hernando; Yuka Sato; Thomas Jensen; Gabriela Garcia; Bernardo Rodriguez-Iturbe; Minoru Ohno; Miguel A Lanaspa; Richard J Johnson
Journal:  Hypertension       Date:  2017-12-04       Impact factor: 10.190

3.  Effect of warfarin on outcomes in septuagenarian patients with atrial fibrillation.

Authors:  Brita Roy; Ravi V Desai; Marjan Mujib; Andrew E Epstein; Yan Zhang; Jason Guichard; Linda G Jones; Margaret A Feller; Mustafa I Ahmed; Inmaculada B Aban; Thomas E Love; Raynald Levesque; Michel White; Wilbert S Aronow; Gregg C Fonarow; Ali Ahmed
Journal:  Am J Cardiol       Date:  2011-11-24       Impact factor: 2.778

Review 4.  Role of oxidative stress in disease progression in Stage B, a pre-cursor of heart failure.

Authors:  Arvind Bhimaraj; W H Wilson Tang
Journal:  Heart Fail Clin       Date:  2011-10-22       Impact factor: 3.179

5.  Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data.

Authors:  Gerasimos S Filippatos; Mustafa I Ahmed; James D Gladden; Marjan Mujib; Inmaculada B Aban; Thomas E Love; Paul W Sanders; Bertram Pitt; Stefan D Anker; Ali Ahmed
Journal:  Eur Heart J       Date:  2011-01-03       Impact factor: 29.983

6.  "Metabolically Healthy" Obesity and Hyperuricemia Increase Risk for Hypertension and Diabetes: 5-year Japanese Cohort Study.

Authors:  Masanari Kuwabara; Remi Kuwabara; Ichiro Hisatome; Koichiro Niwa; Carlos A Roncal-Jimenez; Petter Bjornstad; Ana Andres-Hernando; Yuka Sato; Thomas Jensen; Gabriela Garcia; Minoru Ohno; James O Hill; Miguel A Lanaspa; Richard J Johnson
Journal:  Obesity (Silver Spring)       Date:  2017-09-18       Impact factor: 5.002

7.  Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure.

Authors:  Maciej Banach; Vikas Bhatia; Margaret A Feller; Marjan Mujib; Ravi V Desai; Mustafa I Ahmed; Jason L Guichard; Inmaculada Aban; Thomas E Love; Wilbert S Aronow; Michel White; Prakash Deedwania; Gregg Fonarow; Ali Ahmed
Journal:  Am J Cardiol       Date:  2011-02-04       Impact factor: 2.778

8.  A propensity-matched study of the comparative effectiveness of angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in heart failure patients age ≥ 65 years.

Authors:  Yan Zhang; Gregg C Fonarow; Paul W Sanders; Firoozeh Farahmand; Richard M Allman; Inmaculada B Aban; Thomas E Love; Raynald Levesque; Meredith L Kilgore; Ali Ahmed
Journal:  Am J Cardiol       Date:  2011-09-03       Impact factor: 2.778

9.  Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study.

Authors:  Masanari Kuwabara; Koichiro Niwa; Ichiro Hisatome; Takahiko Nakagawa; Carlos A Roncal-Jimenez; Ana Andres-Hernando; Petter Bjornstad; Thomas Jensen; Yuka Sato; Tamara Milagres; Gabriela Garcia; Minoru Ohno; Miguel A Lanaspa; Richard J Johnson
Journal:  Hypertension       Date:  2017-04-10       Impact factor: 10.190

Review 10.  Uric acid in heart failure: a biomarker or therapeutic target?

Authors:  Marc Kaufman; Maya Guglin
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.